The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Weight loss drugs Ozempic and Wegovy have been added to the list of medications Medicare ... Wegovy, a medication that contains the same main ingredient as Ozempic, semaglutide, is FDA-approved ...

which are considered one product since they all share the same active ingredient, semaglutide. Topping the list are Novo Nordisk's blockbuster diabetes injection Ozempic, weight loss shot Wegovy ...